Articles by tag: lupus-treatment

CAR-T therapy for lupus: 100% remission in a small cohort

German rheumatologists achieved 100% remission in lupus with CAR-T. Four-year data, immune reset mechanism, and forecasts. Read.

Universal CAR-T therapy: FDA allows trials for autoimmune diseases

FDA approved clinical trials of allogeneic CAR-T cell therapy QT-019C for lupus and scleroderma. Savings up to $100 billion, no chemotherapy. Learn about the breakthrough.

Anifrolumab in autoinjector: FDA approves home treatment for lupus

FDA approves Saphnelo Pen for home treatment of lupus. Learn how the anifrolumab autoinjector is changing therapy and reducing access barriers. Details and forecasts.

Saphnelo Pen approved by FDA: treating lupus at home

FDA approved Saphnelo subcutaneous pre-filled pens for lupus treatment. Patients can self-administer the drug without visiting a clinic. Learn about the breakthrough in therapy.